Helping Antibacterial Development to Move Forward – New discovery platforms, novel screens and approaches are vital for the discovery of new antibacterials and for ceasing the dangerous trend of multidrug microbial resistance. Cambridge Healthtech Institute’s 5th Annual Antibacterial Discovery and Development track will focus on the general, strategic issues and solutions that would allow new antibacterial development to move forward. The conference will be held as part of the 5th Annual Re-Entering Antibacterial Discovery and Development Summit, and it will be followed by Targeting Gram-Negative Pathogens.

Kevin Outterson, Executive Director of CARB-X to speak about funding opportunities with CARB-X on September 27th at 8:25am and join the panel discussion at 10:20am.

Mark Albrecht of BARDA to speak on how BARDA is addressing the global threat of antimicrobial resistance on September 27th at 8:45am.